INTERNATIONAL PATENT: UNIVERSITAT DE BARCELONA, FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER, HOSPITAL CLINIC DE BARCELONA FILES APPLICATION FOR "INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 (IL13RALPHA2) TARGETING MOIETIES FOR THE TREATMENT AND PREVENTION OF IL13RALPHA2-POSITIVE CANCER"

GENEVA, July 29 -- UNIVERSITAT DE BARCELONA (Centro de Patentes UB. Baldiri Reixac, 408028 Barcelona), FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER (C/ Rossello 149-15308036 Barcelona), HOSPITAL CLINIC DE BARCELONA (C/ Villarroel 17008036 Barcelona) filed a patent application (PCT/EP2025/051070) for "INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 (IL13Ralpha2) TARGETING MOIETIES FOR THE TREATMENT AND PREVENTION OF IL13Ralpha2-POSITIVE CANCER" on Jan 16, 2025. With publication no. WO/2025/153636, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed b...